There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
<p class="first" id="d10341882e86">This controlled trial examined the benefit of a
high-frequency transcutaneous electrical
nerve stimulation (hfTENS) device (the Quell, NeuroMetrix, Inc., Waltham, MA, U.S.A.)
for patients with chronic low back pain (CLBP).
</p>